Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysis

Immunotherapy, Ahead of Print.

Source: Immunotherapy - November 4, 2019 Category: Allergy & Immunology Authors: Kevin Yan Chakrapani Balijepalli Rohini Sharma Stephane Barakat Shawn X Sun Stephanie Falcao Eric Druyts J Mark FitzGerald Source Type: research